Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,193 | -9,625 | -38,761 | -29,983 | -19,141 |
| Depreciation Amortization | 866 | 437 | 1,729 | 1,296 | 858 |
| Accounts payable and accrued liabilities | -896 | -667 | -1,015 | 465 | 1,142 |
| Other Working Capital | 670 | -1,958 | -966 | -1,361 | -521 |
| Other Operating Activity | 3,876 | 1,333 | 4,558 | 2,233 | 605 |
| Operating Cash Flow | $-18,676 | $-10,481 | $-34,456 | $-27,350 | $-17,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -164 | -181 | -1,506 | -1,161 | -1,138 |
| Purchase Of Investment | -21,990 | -14,320 | -92,680 | -70,734 | -55,056 |
| Sale Of Investment | 39,025 | 19,748 | 113,841 | 85,249 | 58,606 |
| Other Investing Activity | 2 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $16,873 | $5,247 | $19,656 | $13,355 | $2,412 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -505 | -257 | 1,482 | 1,179 | 907 |
| Debt Repayment | N/A | N/A | -1,016 | -757 | -505 |
| Common Stock Issued | 62 | N/A | 19,985 | 19,909 | 19,869 |
| Financing Cash Flow | $-443 | $-257 | $20,451 | $20,331 | $20,271 |
| Beginning Cash Position | 11,726 | 11,726 | 6,075 | 6,075 | 6,075 |
| End Cash Position | 9,480 | 6,236 | 11,726 | 12,412 | 11,703 |
| Net Cash Flow | $-2,246 | $-5,490 | $5,651 | $6,336 | $5,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,676 | -10,481 | -34,456 | -27,350 | -17,056 |
| Capital Expenditure | -164 | -181 | -1,511 | -1,161 | -1,138 |
| Free Cash Flow | -18,840 | -10,662 | -35,967 | -28,511 | -18,194 |